Diseases and Drug Protein Binding
- 1 January 1978
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 3 (2) , 144-154
- https://doi.org/10.2165/00003088-197803020-00004
Abstract
In a number of pathological states a decrease in the plasma protein binding of drugs is observed. This may be due to many factors related either to the protein, or the ligand (drug), or to the binding conditions. The most important of these disease states quantitatively are probably hypoalbuminaemia, conditions resulting in modification of the albumin compartment volume and the presence on albumin binding sites of pathological inhibitors of drug binding. A decrease in the extent of drug plasma protein binding does not necessarily lead to enhanced drug effects and therefore raises two important therapeutic questions. Firstly, does reduced protein binding have a clinically significant influence on the pharmacological effects of the drug? Secondly, if it does, is it preferable to modify the dosage regimen of the drug or to correct the plasma protein concentration prior to the administration of the drug? At present, only tentative answers can be given.This publication has 50 references indexed in Scilit:
- Protein Binding of Cardiac Glycosides in Disease StatesClinical Pharmacokinetics, 1977
- Plasma Protein Binding of Phenytoin and Warfarin in Patients Undergoing Renal Transplantation1Clinical Pharmacokinetics, 1977
- Drug Dosage in Renal DiseaseClinical Pharmacokinetics, 1976
- The Binding of Drugs to Plasma Proteins from Patients with Poor Renal FunctionClinical Pharmacokinetics, 1976
- Renal Failure, Drug Pharmacokinetics and Drug ActionClinical Pharmacokinetics, 1976
- Drug Interactions and Clinical PharmacokineticsClinical Pharmacokinetics, 1976
- Pathophysiological and Disease-Induced Changes in Drug Distribution VolumeClinical Pharmacokinetics, 1976
- Drug Protein Binding and the Nephrotic SyndromeClinical Pharmacokinetics, 1976
- Pharmacokinetics in Patients with Cardiac FailureClinical Pharmacokinetics, 1976
- INTERACTION OF DRUGS WITH THYROID HORMONE BINDING SITES*Annals of the New York Academy of Sciences, 1973